Core Points - Vili Medical's stock closed at 12.28 yuan on May 23, 2025, with a 0.82% increase and a trading volume of 41,500 shares, amounting to a turnover of 51.31 million yuan [1] Group 1: Financial Information - The company announced a cash dividend of 0.5 yuan per share for the 2024 annual equity distribution, with the record date set for May 28, 2025, and the payment date on May 29, 2025 [1][3] - The total cash dividend distribution amounts to 146.43 million yuan based on the total share capital of 292,868,018 shares [1] Group 2: Market Activity - On May 23, 2025, the net outflow of funds from major investors was 3.44 million yuan, while retail investors saw a net inflow of 7.75 million yuan [1][3] Group 3: Regulatory News - Vili Medical's product, the Extraction Bag, received a Class II medical device registration certificate from Health Canada, allowing for legal sales in the Canadian market [2][3] - The certification was issued on May 20, 2025, and is expected to positively impact overseas market promotion and sales [2]

维力医疗2024年年度权益分派实施公告 广州维力医疗器械股份有限公司2024年年度权益分派方案为每股派发现金红利0.5元（含税），共计派 发现金红利146434009元。股权登记日为2025年5月28日，除权（息）日和现金红利发放日为2025年5月 29日。 截至2025年5月23日收盘，维力医疗（603309）报收于12.28元，较上周的12.15元上涨1.07%。本周，维 力医疗5月23日盘中最高价报12.51元。5月19日盘中最低价报12.11元。维力医疗当前最新总市值35.96亿 元，在医疗器械板块市值排名87/126，在两市A股市值排名3681/5148。 本周关注点 公司公告汇总 维力医疗关于控股子公司取得医疗器械经营许可证的公告 广州维力医疗器械股份有限公司控股子公司广州利健益医疗器械科技有限公司获得《第三类医疗器械经 营许可证》，备案编号为粤穗药监械经营许20250562号，有效期从2025年5月7日至2030年5月6日。该证 书的取得不会对公司经营业绩产生重大影响。 维力医疗关于对外投资设立境外孙公司暨关联交易的公告 广州维力医疗器械股份有限公司拟通过全资子公司 WELL LEAD GLOB ...